---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-021726"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:22:50.753347+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Windtree enters $35M equity line, issues $350K convertible note and $405K bridge notes

## Summary
- Common Stock Purchase Agreement with Seven Knots, LLC allows sales up to $35M (or 19.99% outstanding) over 36 months at up to 5% discount to VWAP.
- Issued $350,000 convertible promissory note as commitment fee; 10% interest, convertible at 20% discount to lowest intraday price.
- Issued $287,500 and $117,647 senior secured bridge notes (10% interest, 15% OID) for $350,000 aggregate net proceeds; mandatory redemption from equity line proceeds.
- Equity line purchases require SEC registration effective and common stock price at or above $0.50; company controls timing and amount.
- Company plans to use proceeds for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001437749-24-021726
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774924021726/0001437749-24-021726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774924021726/wint20240630_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-021726
- JSON: https://secwatch.observer/filing/0001437749-24-021726.json
- Plain text: https://secwatch.observer/filing/0001437749-24-021726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.